Uterine Corpus Carcinosarcoma — Trials

Uterine Corpus Carcinosarcoma — Trials · CancerIndex

Clinical trials

Registered studies

15 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 6
Recruiting: 4
Ph III recruiting: 3
Growth YoY: —
Industry share: 0%
Top sponsor: ARCAGY/ GINECO GROUP
Termination share: —

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (3)

clinicaltrialsPublishedShowing 1–3 of 3 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT02874430	Metformin Hydrochloride and Doxycycline in Treating Patients With Localized Breast or Uterine Cancer	terminated	Phase 2	29	Sidney Kimmel Comprehensive Cancer Center at Thomas Jefferson UniversityOTHER	1	Apr 22, 2026	clinicaltrials
NCT04906382	Tislelizumab for the Treatment of Recurrent Mismatch Repair Deficient Endometrial Cancer	terminated	Early Phase 1	2	Floor Backes, MDOTHER	1	Feb 13, 2025